HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Vancomycin in meningitis caused by penicillin G resistant Streptococcus pneumoniae].

Abstract
We report two cases of penicillin G-resistant pneumococcal meningitis in adults, with clinical and bacteriological failure of amoxicillin and negative or incomplete response to third generation cephalosporins. Meningitis occurred in a man treated for myeloma and in an elderly woman under prolonged intermittent amoxicillin therapy for chronic otitis. Such situations are known as exposing to pneumococcal meningitis and to resistance of the strain involved to penicillin G. Both patients were cured by vancomycin in continuous infusion associated with rifampicin or fosfomycin. Contrary to third generation cephalosporins, which have higher minimal inhibitory concentrations, vancomycin and rifampicin are still fully active against penicillin G-resistant pneumococcal strains. Thus, vancomycin administered in continuous infusion and associated with rifampicin and fosfomycin deserves to be tried as first-line treatment of pneumococcal meningitis in patients at risk of resistance to penicillin G.
AuthorsP Longuet, E Vallée, M Michel, C Perronne, M Janvier, C Leport, J L Vildé
JournalPresse medicale (Paris, France : 1983) (Presse Med) Vol. 22 Issue 36 Pg. 1818-9 (Nov 20 1993) ISSN: 0755-4982 [Print] France
Vernacular TitleVancomycine dans les méningites à Streptococcus pneumoniae résistant à la pénicilline G.
PMID8309909 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Vancomycin
Topics
  • Aged
  • Drug Therapy, Combination (therapeutic use)
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Meningitis, Pneumococcal (drug therapy)
  • Penicillin Resistance
  • Vancomycin (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: